Elimination Half-Life
Elimination Half-Life — The time required for the plasma concentration of a compound to decrease by 50% during the elimination phase of pharmacokinetics.
What Is Elimination Half-Life?
Elimination half-life (t1/2β) is the time required for the plasma concentration of a peptide to decrease by 50% during the terminal elimination phase. It is the most commonly reported PK parameter and determines dosing frequency. t1/2 = 0.693 × Vd / CL.
Peptide Half-Life Examples
- Unmodified peptides: 2-30 minutes (rapid protease degradation)
- PEGylated: Hours to days depending on PEG size
- Lipidated (semaglutide): ~7 days (albumin binding reduces renal clearance)
- Fc fusion (dulaglutide): ~5 days (FcRn recycling)
Frequently Asked Questions
What is Elimination Half-Life?
The time required for the plasma concentration of a compound to decrease by 50% during the elimination phase of pharmacokinetics.
Why is Elimination Half-Life important in peptide research?
Elimination Half-Life is a fundamental concept in pharmacology as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.
Authority Sources
- Elimination Half-Life on Wikipedia
- Search Elimination Half-Life on PubChem (NIH)
- Research articles on ScienceDirect